<?xml version='1.0' encoding='utf-8'?>
<document id="19804822"><sentence text="The influence of drug-drug interaction and patients' characteristics on valproic acid's clearance in adults with epilepsy using nonlinear mixed effects modeling."><entity charOffset="72-87" id="DDI-PubMed.19804822.s1.e0" text="valproic acid's" /></sentence><sentence text="Monitoring valproic acid (VPA) concentrations is especially challenging due to its highly variable pharmacokinetics (PK) and complex interactions with other antiepileptic drugs"><entity charOffset="11-24" id="DDI-PubMed.19804822.s2.e0" text="valproic acid" /><entity charOffset="26-29" id="DDI-PubMed.19804822.s2.e1" text="VPA" /><pair ddi="false" e1="DDI-PubMed.19804822.s2.e0" e2="DDI-PubMed.19804822.s2.e0" /><pair ddi="false" e1="DDI-PubMed.19804822.s2.e0" e2="DDI-PubMed.19804822.s2.e1" /></sentence><sentence text=" We used sparse routine therapeutic drug monitoring data (n=200) from 129 adults with epilepsy to develop a population PK model of VPA, and determine the factors that influence its clearance (CL/F)"><entity charOffset="131-133" id="DDI-PubMed.19804822.s3.e0" text="VPA" /></sentence><sentence text=" Patients were on mono VPA therapy, or were concomitantly treated with carbamazepine, phenobarbital, topiramate (TPR), lamotrigine or benzodiazepines"><entity charOffset="71-84" id="DDI-PubMed.19804822.s4.e0" text="carbamazepine" /><entity charOffset="86-99" id="DDI-PubMed.19804822.s4.e1" text="phenobarbital" /><entity charOffset="101-111" id="DDI-PubMed.19804822.s4.e2" text="topiramate" /><entity charOffset="113-116" id="DDI-PubMed.19804822.s4.e3" text="TPR" /><entity charOffset="119-130" id="DDI-PubMed.19804822.s4.e4" text="lamotrigine" /><entity charOffset="134-149" id="DDI-PubMed.19804822.s4.e5" text="benzodiazepines" /><entity charOffset="23-37" id="DDI-PubMed.19804822.s4.e6" text="VPA" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e6" e2="DDI-PubMed.19804822.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e6" e2="DDI-PubMed.19804822.s4.e0" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e6" e2="DDI-PubMed.19804822.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e6" e2="DDI-PubMed.19804822.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e6" e2="DDI-PubMed.19804822.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e6" e2="DDI-PubMed.19804822.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e6" e2="DDI-PubMed.19804822.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e0" e2="DDI-PubMed.19804822.s4.e0" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e0" e2="DDI-PubMed.19804822.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e0" e2="DDI-PubMed.19804822.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e0" e2="DDI-PubMed.19804822.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e0" e2="DDI-PubMed.19804822.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e0" e2="DDI-PubMed.19804822.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e1" e2="DDI-PubMed.19804822.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e1" e2="DDI-PubMed.19804822.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e1" e2="DDI-PubMed.19804822.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e1" e2="DDI-PubMed.19804822.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e1" e2="DDI-PubMed.19804822.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e2" e2="DDI-PubMed.19804822.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e2" e2="DDI-PubMed.19804822.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e2" e2="DDI-PubMed.19804822.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e2" e2="DDI-PubMed.19804822.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e3" e2="DDI-PubMed.19804822.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e3" e2="DDI-PubMed.19804822.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e3" e2="DDI-PubMed.19804822.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e4" e2="DDI-PubMed.19804822.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19804822.s4.e4" e2="DDI-PubMed.19804822.s4.e5" /></sentence><sentence text=" A one-compartment model with first-order absorption and elimination was used to fit the concentration-time VPA data"><entity charOffset="108-110" id="DDI-PubMed.19804822.s5.e0" text="VPA" /></sentence><sentence text=" Estimates generated by NONMEM indicated that VPA CL/F was influenced by the patients' body weight (increases with the 0"><entity charOffset="46-48" id="DDI-PubMed.19804822.s6.e0" text="VPA" /></sentence><sentence text="556 exponent), VPA daily dose (if it is greater than 1000 mg/day, CL/F increases by 43%), and co-therapy with TPR (lowering CL/F for 23%)"><entity charOffset="15-17" id="DDI-PubMed.19804822.s7.e0" text="VPA" /><entity charOffset="110-112" id="DDI-PubMed.19804822.s7.e1" text="TPR" /><pair ddi="false" e1="DDI-PubMed.19804822.s7.e0" e2="DDI-PubMed.19804822.s7.e0" /><pair ddi="false" e1="DDI-PubMed.19804822.s7.e0" e2="DDI-PubMed.19804822.s7.e1" /></sentence><sentence text=" The interindividual variability in VPA CL/F was modeled with exponentional error model"><entity charOffset="36-38" id="DDI-PubMed.19804822.s8.e0" text="VPA" /></sentence><sentence text=" The estimated coefficient of variation was 31" /><sentence text="9%, while the residual variability was 23" /><sentence text="8% for the proportional and 13" /><sentence text="2mg/l for the additive component" /><sentence text=" The model was validated in a separate set of 24 patients, and the predictive performance was evaluated, that indicated unbias and acceptable precision" /><sentence text=" This study confirms the interaction of VPA with TPR, which is presumably dependent on VPA dose"><entity charOffset="40-42" id="DDI-PubMed.19804822.s14.e0" text="VPA" /><entity charOffset="87-89" id="DDI-PubMed.19804822.s14.e1" text="VPA" /><entity charOffset="49-51" id="DDI-PubMed.19804822.s14.e2" text="TPR" /><pair ddi="false" e1="DDI-PubMed.19804822.s14.e0" e2="DDI-PubMed.19804822.s14.e0" /><pair ddi="false" e1="DDI-PubMed.19804822.s14.e0" e2="DDI-PubMed.19804822.s14.e2" /><pair ddi="false" e1="DDI-PubMed.19804822.s14.e0" e2="DDI-PubMed.19804822.s14.e1" /><pair ddi="false" e1="DDI-PubMed.19804822.s14.e2" e2="DDI-PubMed.19804822.s14.e2" /><pair ddi="false" e1="DDI-PubMed.19804822.s14.e2" e2="DDI-PubMed.19804822.s14.e1" /></sentence><sentence text="" /></document>